ANP Receptor Subtypes on Cells of the Aqueous Inflow and Outflow
Principal Investigator
Richard Crook, PhD
University of California, San Francisco
San Francisco, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$24,582
Active Dates
April 01, 1994 - March 31, 1995
Grant ID
G1994316
Summary
Recent genetic evidence has raised the possibility that a particular protein in the eye (a neuropeptide receptor, ANPR-A) could be involved in the etiology of juvenile glaucoma in one family. This project aims to identify the location of this protein in tissues in the front of the eye, and to determine how the function of this protein and related proteins are controlled by hormonal and other factors in the eye. An understanding of how this protein functions may provide insights into this form of glaucoma. The ANP receptor subtypes will be distinguished by subtype preferences for various natriuretic peptides resulting in guanylate cyclase activation and by binding of labeled ANP to intact cells. Regulation of ANP receptor subtype function will be studied by measuring the effects of various hormones, neurotransmitters and other activators of second messenger pathways on natriuretic peptide stimulation of guanylate cyclase and labeled ANP binding to intact cells.
Related Grants
National Glaucoma Research
Novel Visualization of Aqueous Outflow: Uncovering Glaucoma Mechanisms and Therapeutic Targets
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Tyson Kim, MD, PhD
Current Organization
University of California, San Francisco
Novel Visualization of Aqueous Outflow: Uncovering Glaucoma Mechanisms and Therapeutic Targets
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Tyson Kim, MD, PhD
Current Organization
University of California, San Francisco
National Glaucoma Research
How Neural Activity Shapes Vision Recovery in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Yvonne Ou, MD
Current Organization
University of California, San Francisco
How Neural Activity Shapes Vision Recovery in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Yvonne Ou, MD
Current Organization
University of California, San Francisco
National Glaucoma Research
Activating the Eye’s Own Nitric Oxide to Fight Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Myoungsup Sim, PhD
Current Organization
Duke University School of Medicine
Activating the Eye’s Own Nitric Oxide to Fight Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Myoungsup Sim, PhD
Current Organization
Duke University School of Medicine